Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The role of hepatic insulin receptors in the regulation of glucose production
Alan D. Cherrington
Alan D. Cherrington
Published May 2, 2005
Citation Information: J Clin Invest. 2005;115(5):1136-1139. https://doi.org/10.1172/JCI25152.
View: Text | PDF
Commentary

The role of hepatic insulin receptors in the regulation of glucose production

  • Text
  • PDF
Abstract

The inability of insulin to suppress hepatic glucose production (HGP) is a key defect found in type 2 diabetes. Insulin inhibits HGP through both direct and indirect means, the latter of which include inhibition of glucagon secretion, reduction in plasma nonesterified fatty acid level, decrease in the load of gluconeogenic substrates reaching the liver, and change in neural signaling to the liver. Two studies in this issue of the JCI demonstrate that selective changes in the expression of insulin receptors in mouse liver do not have a detectable effect on the ability of insulin to inhibit HGP (see the related articles beginning on pages 1306 and 1314). These provocative data suggest that the indirect effects of insulin on the liver are the primary determinant of HGP in mice.

Authors

Alan D. Cherrington

×

Total citations by year

Year: 2025 2019 2018 2017 2015 2014 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 1 5 1 2 2 2 1 1 1 1 2 1 4 24
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (24)

Title and authors Publication Year
Therapeutic Potential of Myricitrin in a db/db Mouse Model of Type 2 Diabetes
Kim SR, Kim YJ, Kim H, Park S, Jung UJ
Molecules 2025
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver
Justin A. Fletcher, Stanislaw Deja, Santhosh Satapati, Xiaorong Fu, Shawn C. Burgess, Jeffrey D. Browning
JCI Insight 2019
The integrative biology of type 2 diabetes
M Roden, GI Shulman
Nature 2019
Honokiol Improves Insulin Resistance, Hepatic Steatosis, and Inflammation in Type 2 Diabetic db/db Mice
YJ Kim, UJ Jung
International journal of molecular sciences 2019
Non-islet Cell Hypoglycemia: Case Series and Review of the Literature
V Garla, H Sonani, V Palabindala, C Gomez-Sanchez, J Subauste, LF Lien
Frontiers in Endocrinology 2019
Sex Dependent Dysregulation of Hepatic Glucose Production in Lean Type 2 Diabetic Rats
CS Blesson, A Schutt, S Chacko, JC Marini, PR Mathew, D Tanchico, M Balakrishnan, C Yallampalli
Frontiers in Endocrinology 2019
Mechanisms of Insulin Action and Insulin Resistance
MC Petersen, GI Shulman
Physiological reviews 2018
Physical exercise reduces pyruvate carboxylase (PCB) and contributes to hyperglycemia reduction in obese mice
VR Muñoz, RC Gaspar, BM Crisol, GP Formigari, MR SantAna, JD Botezelli, RS Gaspar, AS da Silva, DE Cintra, LP de Moura, ER Ropelle, JR Pauli
The Journal of Physiological Sciences 2017
FoxO integration of insulin signaling with glucose and lipid metabolism
S Lee, HH Dong
Journal of Endocrinology 2017
The new biology of diabetes
UB Pajvani, D Accili
Diabetologia 2015
Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear.
Rini CJ, McVey E, Sutter D, Keith S, Kurth HJ, Nosek L, Kapitza C, Rebrin K, Hirsch L, Pettis RJ
Drug Delivery and Translational Research 2015
Control of hepatic glucose metabolism by islet and brain
JM Rojas, MW Schwartz
Diabetes Obesity and Metabolism 2014
Role for the TRPV1 channel in insulin secretion from pancreatic beta cells.
Diaz-Garcia CM, Morales-Lázaro SL, Sánchez-Soto C, Velasco M, Rosenbaum T, Hiriart M
The Journal of Membrane Biology 2014
Central nervous system control of metabolism
MG Myers, DP Olson
Nature 2012
Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis
JD O'Hare, E Zielinski, B Cheng, T Scherer, C Buettner
Diabetes 2011
FoxOs Function Synergistically to Promote Glucose Production*
RA Haeusler, KH Kaestner, D Accili
The Journal of biological chemistry 2010
Brain insulin infusion does not augment the counterregulatory response to hypoglycemia or glucoprivation
KK Ishihara, SC Haywood, D Daphna-Iken, EC Puente, SJ Fisher
Metabolism 2009
Inducible gene silencing defines CNS insulin action as a major determinant of peripheral glucose and fat metabolism
Linda Koch1, F. Thomas Wunderlich1, Jost Seibler2, A. Christine Könner1, Brigitte Hampel1, Sigrid Irlenbusch1, Georg Brabant3, C. Ronald Kahn4, Frieder Schwenk2,5, Jens C. Brüning1
Journal of Clinical Investigation 2008
An explorative study of in vivo digestive starch characteristics and postprandial glucose kinetics of wholemeal wheat bread
MG Priebe, RE Wachters-Hagedoorn, JA Heimweg, A Small, T Preston, H Elzinga, F Stellaard, RJ Vonk
European Journal of Nutrition 2008
Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum
CM Kusminski, PG McTernan, T Schraw, K Kos, JP OHare, R Ahima, S Kumar, PE Scherer
Diabetologia 2007
Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice
M Simmgen, C Knauf, M Lopez, AI Choudhury, M Charalambous, J Cantley, DC Bedford, M Claret, MA Iglesias, H Heffron, PD Cani, A Vidal-Puig, R Burcelin, DJ Withers
Diabetologia 2006
Central nervous system and control of endogenous glucose production
G Demuro, S Obici
Current Diabetes Reports 2006
Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN
CM Taniguchi, TT Tran, T Kondo, J Luo, K Ueki, LC Cantley, CR Kahn
Proceedings of the National Academy of Sciences 2006
Insulin’s effect on the liver: “Direct or indirect?” continues to be the question
J Girard
Journal of Clinical Investigation 2006

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts